Trimethoprim (AvPAK)


Welcome to the PulseAid listing for the Trimethoprim drug offered from AvPAK. This Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AvPAK
NON-PROPRIETARY NAME: Trimethoprim
SUBSTANCE NAME: TRIMETHOPRIM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-07-31
END MARKETING DATE: 0000-00-00


Trimethoprim HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTrimethoprim from AvPAK
LABELER NAME: AvPAK
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 2013-07-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50268-775_60fe1c72-6583-8bf3-c896-c983485a78ca
PRODUCT NDC: 50268-775
APPLICATION NUMBER: ANDA070049

Other TRIMETHOPRIM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Trimethoprim
AvKARE, Inc.Trimethoprim
AvPAKTrimethoprim
Carilion Materials ManagementTrimethoprim
Lupin Pharmaceuticals,Inc.Trimethoprim
Mayne Pharma Inc.Trimethoprim
Novel Laboratories, Inc.Trimethoprim
Physicians Total Care, Inc.Trimethoprim
Teva Pharmaceuticals USA, Inc.Trimethoprim